This report is an updated version of the report published on 3 September 2026 at 10:53 AM AEST.

Company Overview: Aroa Biosurgery Limited (ASX: ARX) is a soft-tissue regeneration company dedicated to unlocking regenerative healing for everyone. The company develops and distributes advanced wound care and surgical products using its proprietary AROA ECM™ technology, derived from sheep forestomach. Its innovations support faster, more effective healing in complex wounds and soft tissue reconstruction. Kalkine’s Inflation Report covers the Investment Highlights, Key Financial Metrics, Risks, Outlook, Technical Analysis along with the Valuation, Target Price, and Recommendation on this one stock.

Section 1: Introduction

Past performance is not a reliable indicator of future performance.